TB500.

TB-500 (Thymosin Beta-4 Fragment) is a synthetic 43-amino acid peptide representing the active region of the naturally occurring Thymosin Beta-4 protein. With the molecular formula C₂₁₂H₃₅₀N₅₆O₇₈S and...

$52.00

Select Protocol

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for TB500.

G-actin sequestration

Actin Cytoskeleton

TB-500 binds to monomeric G-actin, regulating actin polymerization and cytoskeletal dynamics in cell culture models.

Integrin signaling

Cell Migration

Published studies demonstrate effects on cell motility through interactions with integrin receptors and focal adhesion dynamics.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on TB500 molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of TB500 in standardized assay systems.

Preclinical

TB500 structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of TB500 in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring